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Abstract 
HealthyWeighHub (HWH) is a 12-month coaching and education service designed to help patients with obesity 
make permanent life changes, launched and expanded gradually in Helsinki University Hospital (HUS) Healthvillage 
since 2016.  
We examined the direct secondary care cost benefits of HWH, measured with potential capacity freed (PCF) com-
pared to conventional group coaching (CGC). Costs included health care, patient co-payments and travelling ex-
penses. First, we evaluated the PCF actualized in the first two years from 2016 to 2018 in the HUS Specific Catch-
ment Area (HUS ERVA). Then, we predicted the PCF at Finnish national level, if HWH was implemented gradually 
over the five years from 2018 to 2022, aimed at treating 1 % of adults with obesity annually in 2022. 
HWH’s actualized PCF was €2.69 million compared to CGC in the first two years in HUS ERVA. If the patients who 
received CGC had been treated with HWH instead, total PCF could have been €3.71 million. At Finnish national 
level, providing CGC to 1 % of adults with obesity was predicted to cost €28.0 million (€5.08 per capita) annually in 
2022. With HWH predicted cost was €7.31 million (€1.33 per capita), meaning an annual PCF of €20.7 million 
(€3.75 per capita) in 2022 and cumulative five-year PCF of €57.5 million (€10.43 per capita). Compared to CGC, 
HWH is estimated to enable treatment of approximately 3.8-times more patients with obesity at the same cost.  
HWH can be more affordable than CGC and a potentially efficient tool to combat the obesity epidemic. Future 
evaluations should examine HWH’s effectiveness and impact on the indirect costs associated with weight loss and 
long-term illness. 
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Introduction 
Obesity and obesity-related morbidities are an enor-
mous public health problem in Finland and world-wide. 
Latest estimates indicate that approximately 68 % and 
58 % of the adult Finnish men and women are over-
weight (body mass index, BMI ≥ 25 kg/m2), and 24 % 
and 26 % have obesity (BMI ≥ 30 kg/m2), respectively 
[1,2]. That is, there are approximately 2.8 million over-
weight and 1.1 million individuals with obesity among 
the 4.5 million adult Finns.  
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Obesity increases the risk of many conditions and dis-
eases, such as, type 2 diabetes, hyperglycemia, hyper-
tension, dyslipidemia, fatty liver, sleep apnea, cardio-
vascular disease, arthrosis and asthma, all posing a 
significant threat to patients’ life expectancy and quali-
ty of life [2]. Consequently, the treatment of obesity 
aims at prevention and management of obesity-
associated conditions. Moreover, modern approaches 
are based on behavioral changes that modify daily life-
style and require comprehensive and sufficiently long 
patient-centered intervention to facilitate long-term 
change in individual’s behavior [3,4].  
However, provision of sufficiently comprehensive 
treatment in person on a large scale is challenging, 
given the resource and budget restrictions of the real-
life health care systems. To address this, web-based 
weight loss and lifestyle interventions have been stud-
ied rather extensively to find more efficient ways to 
deliver interventions (e.g., [5-11]). In line with the mod-
ern eHealth developments, Helsinki University Hospital 
District (HUS) launched the Healthvillage (Terveysky-
lä.fi) online portal in the spring of 2016. Alongside the 
Healthvillage platform, a new web-based treatment 
program for obesity, HealthyWeightHub (HWH), was 
first established in October 2016. HWH is a 12-month 
long virtual coaching service, designed to help patients 
to make permanent behavioral changes. Currently, 
HWH is available nationally free of cost for all Finnish 
citizens with a BMI > 25 kg/m2, based on referral from 
any licensed physician. Although HWH collects relevant 
health outcome data, it is not available at this time.  
While the observed effects of various previous web-
based weight loss and lifestyle programs implemented 
in different settings have ranged from poor to excellent 
[5-11], previous literature does suggest that modern, 
digitalized and comprehensive approaches can have the 
potential to improve availability and cost-efficiency of 
weight loss management [6-8,12]. 
Previously, digitalized secondary care services with 
Virtual Hospital 2.0 were modelled to have a substantial 
potential to free health care capacity at aggregate Finn-
ish level [12]. In addition, a recent study demonstrated 
that web-based health behavior change support can be 
efficacious in achieving and maintaining weight loss up 
to 24 months in the Finnish setting, independent of 
whether the web-based support is given in addition 
face-to-face sessions or not [8]. However, no real-world 
data (RWD) on the effectiveness, utilization or costs of 
online programs using novel interactive technologies 
including virtual coaching in treatment of obesity in the 
Finnish setting exist. While previous studies have indi-
cated that web-based lifestyle intervention can be effi-
cacious [7,8], and also more affordable than face-to-
face programs [6,7], these findings are not readily 
transferable to other health care settings or web-based 
interventions, with different contents or implementa-
tion methods, such as HWH.  
Thus, in the present study our aim was to: 
1. Evaluate the already actualized cost benefits of 
HWH at HUS Specific Catchment Area (HUS ERVA) 
based on retrospective RWD, and 
2. Predict potential cost-benefits of nationwide 
implementation of HWH at Finnish national level.  
 
Materials and methods 
This cost-benefit analysis followed the health technolo-
gy assessment (HTA) pathway for the suitable and ap-
plicable parts. Thus, PICOSTEPS principle (Patients – 
Intervention – Comparator – Outcome – Setting – Time 
– Effects – Perspective – Sensitivity) structural analysis 
and reporting principle was applied, as PICOSTEPS re-
ports the content of health economic evaluations such 
as cost-effectiveness, cost-utility, cost-benefit, cost 
minimization, value of information, risk-benefit or RWD 
in the order of importance [13-16]. PICOSTEPS covers 
the content of the official cost-effectiveness analysis 
guidelines by the Finnish Pharmaceuticals Pricing Board 
[17] and is line with the HTA recommendations by the 
Finnish Medicines Agency [18] and Finnish Medical 
Society Duodecim [19].  
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Patients 
Analyses considered the patients receiving intervention 
for obesity in the 1) the HUS Specific Catchment Area 
(HUS ERVA) and 2) Finland national level generally. 
Between October 2016 and October 2018, a total of 
1,518 patients received HWH at HUS ERVA (83, 492 and 
943 patients in years 2016, 2017 and 2018, respective-
ly). A total of 577 patients received conventional group 
coaching (CGC) between January 2016 and October 
2018 (243, 194 and 140 patients in 2016, 2017 and 
2018, respectively).  
Based on the FinTerveys 2017 study, approximately 
24.4 % and 26.0% of adult Finnish men and women 
aged 18 years or older have obesity (BMI at least 30 
kg/m2), respectively [1]. With the population of 2.128 
million adult men and 2.278 million adult women [20], 
approximately 1,125 million adult Finns have obesity.  
For the predictive national level analyses, a minor-to-
modest treatment goal was assumed: treat 1 % of these 
adults with obesity (i.e. 11,250) annually by the year 
2022. This target corresponds well to historical average 
annual increase in the number of individuals with obesi-
ty aged 20 to 64 years in Finland between 1980 and 
2018 [21]. In essence, the approximate analytical target 
was set to stop the number of Finns with obesity in-
creasing by year 2022. 
 
Intervention and Comparator 
The intervention, HWH, is a mobile, structured and 
automated 12-month intervention that encompasses 
weekly training sessions and a wide spectrum of differ-
ent approaches (diet, physical activity, sleep, psycholo-
gy, coping for stress, health). With approximately 200 
alternatives, the participants can also freely choose 
sessions to best match their individual taste. Around 60 
training sessions are on video or audio in the HWH, to 
widen the range of treatment modalities and to in-
crease motivation. The participants can submit weight 
and diet logs to the HWH, for which they receive feed-
back. In addition to the automated, interactive pro-
gram, HWH includes a virtual personal coach allocated 
to each patient. 
The HWH uses the five technical key components that 
have been shown to significantly decrease weight in 
guided internet-delivered weight loss programs: 1) self-
monitoring, 2) counsellor feedback and communication, 
3) group support, and the use of 4) structured and 5) 
individually tailored programs [5]. The HWH has a 
strong psychological framework – acceptance and 
commitment therapy (ACT) – to increase mindfulness 
and psychological flexibility in lifestyle change [22]. ACT 
is a so-called ‘new wave’ of cognitive behavioral thera-
py; it supports flexible decisions in everyday life that – 
in contrast to rigid rules – have a long-lasting effect 
[23,24].  
HWH was compared to conventional group coaching 
(CGC) provided in the secondary health care. Finnish 
Current Care Guidelines acknowledge that CGC usually 
comprises 5 to 15 group sessions of dietetic and/or 
psychological group counselling aimed at examining 
patient’s situation and promoting change, controlling 
eating habits, restricting caloric intake and securing 
sufficient nutrition from diet, and increasing physical 
activity [2]. The group sizes and methods of implement-
ing CGC vary regionally and by provider.  
 
Outcomes 
The primary cost-benefit outcome was the estimated 
and predicted potential capacity freed (PCF) at the HUS 
ERVA and Finnish national level, allowed by the HWH, 
respectively. Health care market mechanisms can fail, 
causing imbalance between demand and supply and 
health care can be luxury good demanded in increasing 
amounts (see e.g. [25]), for multiple reasons (see e.g. 
[26]). Thus, cost-savings achieved with more efficient 
service provision may not translate into total budgetary 
savings because the saved monies are usually reallocat-
ed to meet the demand or need remaining elsewhere. 
In addition, the saved monies may produce more health 
benefits in their reallocation – especially when the 
production technology changes [27]. This in mind, PCF 
denotes the monetary potential for allocating health 
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care and health care related resources to meet the 
demand, need or health benefit production elsewhere. 
PCF can crudely be considered as cost-savings available 
for reallocation, for instance, treating more patients 
within the same budgetary limitations.  
In present analyses PCF was estimated at year 2017 real 
values (euros). Per capita PCF were estimated in Finnish 
national level analyses using 2018 year-end total Finn-
ish population of 5,517,919 individuals [20]. No dis-
counting or mid-year estimates were applied. 
 
Settings and Time 
Cost-benefit analyses were conducted in two settings 
and time horizons. First, the actualized cost benefits of 
using HWH instead of CGC at HUS ERVA level during the 
first two years of HWH implementation were evaluated. 
Analysis was carried out in retrospective setting utilizing 
counterfactual estimation, evaluating scenario where 
patients treated with HWH in a two-year period be-
tween October 2016 and October 2018 would have 
been treated with CGC instead. In addition, it was also 
counterfactually evaluated how much additional PCF 
could have been gained, if patients treated with CGC 
from January 2016 to October 2018 had been treated 
with HWH instead.  
Second, a predictive analysis examining the PCF by 
implementation of HWH at Finnish national level was 
modelled over a 5-year time horizon from year 2018 to 
2022. Analysis was carried out in annual calculations 
and was based on an expectation that nationwide HWH 
implementation, with the goal of treating 1% of the 
Finns with obesity annually by 2022, was initiated in the 
beginning of 2018 and completed gradually in five 
years.  
 
Effects 
HWH cost is fixed: The service is free for the patient, 
but the hospital district referring the patient for HWH is 
billed €650 per patient for the 12-month intervention. 
The HWH does not incur any patient fees or travelling 
expenses.  
Expected resource use (i.e. secondary care treatment, 
patient fees, travelling) and unit costs of CGC were 
based on the Finnish RWD and expert information. On 
average, patients in CGC were modelled to attend 11.8 
group coaching sessions, costing a total of €2,070 per 
patient. In addition, each visit was associated with a 
patient fee and travelling expense.  
Year 2018 HUS patient fees were used for series visits 
(€11.40 per visit) for the HUS ERVA level analysis and 
estimated average national fee in Finland (€10.96 per 
visit) for the Finnish national level analysis. The average 
national level patient fee was estimated by weighting 
the specific catchment area patient fees for series visits 
(ranging €9.00 to €11.40) with the number of inhabit-
ants living in each area (ranging from 0.741 to 2.15 
million in 31.12.2016 [28]). 
Travelling expenses were based on statistics of reim-
bursed travels [29, 30] and local bus tariffs. Depending 
on the specific catchment area, approximately 9.8 % to 
19.4 % of the trips were reimbursed by the Social Insur-
ance Institute in 2015 [29]. The average cost of reim-
bursed two-way travel was estimated as the twice the 
average reimbursed one-way trip cost in the specific 
catchment area (ranging from €66.83 to €92.91 in year 
2017 [30]). All non-reimbursed travels were modelled 
conservatively (i.e. not benefitting HWH), and for sim-
plicity, to incur two cheapest local bus tickets in the 
specific catchment area main cities (ranging from €2.90 
to €3.30 per ticket). The weighted averages of reim-
bursed and non-reimbursed travel costs were utilized in 
the analyses.  
For HUS ERVA the average travelling expense was esti-
mated at €18.29 per visit. The average national level 
travelling expense of €24.58 per visit were estimated by 
weighting the estimated specific catchment area travel-
ling costs (estimated at €18.29, €21.52, €23.87, €30.00 
and 41.30 € per visit in Helsinki, Turku, Tampere, Kuo-
pio and Oulu specific catchment areas, respectively) 
with the number of inhabitants in each area. 
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Perspective 
Based on the Finnish health economic evaluation guide-
line [17] and HTA recommendations [18,19], analyses 
were conducted from the perspective of secondary 
health care payer covering only direct secondary care 
costs and travelling expenses, which were expected be 
a significant driver of direct cost benefits [31,32] along 
with the secondary care costs. Although e.g. primary 
care costs are generally important to account for [33], 
direct primary care and social care costs, as well as 
long-term secondary care costs, were excluded due to 
lack of data.  
Moreover, while very important in wider societal per-
spectives [32,34], indirect costs, such as sickness allow-
ances, pensions, absenteeism, presenteeism, educa-
tion, unemployment, household chores, taxes and 
other income transfers, were excluded, as the payer 
perspective was used. Neither were any potential bene-
fits in reducing costs due to long-term morbidity associ-
ated with the obesity analyzed. Thus, in essence, no 
impact was assumed to other than short-to-moderate 
term secondary health care related budgets, constitut-
ing quite a conservative analysis setting for HWH.  
 
Sensitivity analyses 
As the analyses examining the actualized PCF in 2016 to 
2018 were based on RWD from HUS ERVA, no sensitivi-
ty analyses were conducted for these analyses.  
For the predictive analyses examining the potential 
nationwide implementation of HWH, deterministic 
sensitivity analyses were carried out examining impact 
of 20 % decrease or increase in the 1) average number 
of visits (and costs) associated with the CGC and 2) 
number of patients treated in 2022. 
 
Results 
Cost-benefits at the HUS ERVA area in 2016 to 2018Q3 
HWH’s actualized PCF was €2.69 million over the first 
two years between October 2016 and October 2018 at 
the HUS ERVA level, compared to a scenario where 
patients treated with HWH would have received CGC 
instead of HWH (Figure 1). Care was the largest driver 
of PCF (€2.16 million; 80 % of total PCF), followed by 
travel expenses (€0.33 million; 12 %) and patient fees 
(€0.20 million; 8 %). 
Furthermore, if all patients who received CGC between 
January 2016 and October 2018 had been treated with 
HWH instead of CGC, additional €1.02 million of capaci-
ty could have been freed at the HUS ERVA level (Figure 
2). Approximately €0.82 million could have been freed 
from care, €0.12 million from travelling expenses and 
from €0.08 million from patient fees. Consequently, the 
total PCF at the HUS ERVA level could have been ap-
proximately €3.71 million already during the first two 
years of HWH being available. 
 
 
    
SCIENTIFIC PAPERS 
 
 
6.11.2019    FinJeHeW 2019;11(4)  347 
 
Figure 1. Estimated actualized potential capacity freed with the HealthyWeightHub at HUS ERVA in two years be-
tween October 2016 and October 2018. 
 
Figure 2. Potential capacity that could have been freed at HUS ERVA, if the patients receiving conventional group 
coaching between January 2016 and October 2018 had received HealthyWeightHub intervention instead. 
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Predicted cost-benefits at the Finnish national level 
over five years 
At the Finnish national level, treating 1 % of the adults 
with obesity with CGC was estimated to cost approxi-
mately €28.0 million (€5.08 per capita, 2018 year-end 
Finnish population) in 2022 (Figure 3). In comparison, 
treating the same number of patients with HWH was 
estimated to cost only €7.31 million (€1.33 per capita; 
26 % of the CGC cost), resulting in annual PCF of €20.7 
million (€3.75 per capita) in 2022. At the Finnish nation-
al level, PCF from travelling expenses accounted for 16 
% of the total estimated PCF.  
The cumulative five-year PCF due to treating 1 % of the 
adults with obesity by 2022 with HWH would be €57.5 
million (€10.43 per capita) at the Finnish national level 
compared to CGC. Approximately €44.4 million (€8.05 
per capita; 77 %) of PCF would come from care. Overall, 
approximately 3.8 times more patients could be treated 
with HWH than possible with the CGC in a fixed budget 
situation. 
The sensitivity analyses with 20% lower and higher CGC 
costs and visits demonstrated that the estimated annu-
al cost of CGC in 2022 varied between €22.4 and €33.6 
million (€4.06 and €6.09 per capita), with the respective 
estimated annual PCF achieved with HWH varying from 
€15.1 (67 % of total CGC costs) to €26.3 (78 %) million 
in 2022 (€2.74 to €4.77 per capita) and total 5-year PCF 
varying from €42.0 to €73.1 million (€7.61 to €13.25 per 
capita; Figure 4).  
Treating 20 % less or 20 % more patients by 2022 would 
result in annual cost of HWH of €5.85 to €8.78 million 
(€1.06 and €4.06 per capita) in 2022, respectively (Fig-
ure 5). The consequent estimated annual PCF in 2022 
and total estimated 5-year PCF in 2018-2022 varied 
from €16.6 to €24.8 million (€3.00 to €4.50 per capita) 
and from €47.2 to €67.9 million (€8.55 to €12.30 per 
capita), respectively, but had no impact on the relative 
PCF. .
 
Figure 3. Predicted potential capacity freed at the Finnish national level, if the HealthyWeightHub was implement-
ed gradually over five years between 2018 and 2022, and the goal was set to treat 11,250 patients with obesity 
annually in the year 2022.  
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Figure 4. Sensitivity analyses for the predicted potential capacity freed at the Finnish national level, if the 
HealthyWeightHub was implemented gradually over five years between 2018 and 2022, and the goal was set to 
treat 11,250 patients with obesity annually in the year 2022. A) 20 % lower and B) 20 % higher conventional group 
coaching visits and costs. 
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Figure 5. Sensitivity analyses for the predicted capacity freed, if the HealthyWeightHub was implemented gradually 
over five years between 2018 and 2022, and the goal was set to treating A) 9,000 and B) 13,500 patients with obe-
sity annually in the year 2022. 
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Discussion 
The present cost-benefit study examined the actualized 
and predicted potential capacity freed (PCF) when sub-
stituting the conventional group coaching (CGC) with 
the modern, comprehensive digitalized program, 
HealthyWeightHub (HWH), in the treatment of patients 
with obesity in HUS Specific Catchment Area (HUS 
ERVA) and at the Finnish national level, respectively. 
Assessment was conducted from the payer perspective, 
with the underlying question being whether the payer 
(e.g. municipality) should arrange HWH or CGC. From 
payer’s perspective, development, investment, produc-
tion, maintenance and many other types of producer 
costs are all included in the price accepted by the payer. 
Thus, these costs were not considered explicitly here. 
Explicit assessment of these costs could be relevant for 
internal accounting, a producer perspective analysis or 
wide societal perspective assessing different drivers of 
costs. However, in the case these costs were explicitly 
included, they would need to be included for both HWH 
and CGC. 
Overall, data indicates that HWH’s actualized PCF was 
cumulatively €2.69 million already in the first two years 
from October 2016 to October 2018 in HUS ERVA. HWH 
would have had resulted to the additional estimated 
PCF of €1.02 million, had CGC been replaced completely 
with HWH in January 2016 and onwards. At the Finnish 
national level, the predicted PCF was also considerable, 
when the set target was to approximately stop the 
increase in the number of adults with obesity in Finland 
by 2022. The annual PCF in 2022 was predicted at €20.7 
million (€3.75 per capita) or 74 % of the predicted an-
nual CGC costs. Thus, approximately 3.8 times more 
patients could be treated with the same costs, if HWH is 
used instead of the CGC in a fixed budget setting. Given 
these results, the HWH is seen as a very potential solu-
tion to combat the increasing obesity epidemic in Fin-
land, and perhaps in other settings with obesity chal-
lenges.  
Only a few earlier studies have assessed the health 
economic aspects of eHealth services in Finland, and no 
published study has examined cost benefits of compre-
hensive web-based treatment programs for patients 
with obesity in the Finnish setting. In a dynamic model-
ling-based cost-benefit assessment at total aggregate 
Finnish national level, the five-year cumulative PCF with 
Virtual Hospital 2.0 related to the secondary care was 
estimated to be €1.3 billion [12]. While studies examin-
ing other web-based weight loss interventions in health 
care settings outside Finland are not easily transferable 
to Finnish setting, nor applicable in evaluation of cost 
benefits of HWH, the previously published foreign cost-
effectiveness studies [6,7] give encouraging support to 
our finding that HWH can be affordable alternative to 
CGC.  
In a 24-week study of 49 Hong Kong patients examining 
a web-based intervention much less comprehensive 
than HWH, Chung et al. found that, compared to 12 
weekly face-to-face private counselling sessions with 
dietary log book, a program of three 2-hour seminars 
with interactive web-based dietary records and dietitian 
feedback resulted in significantly larger weight (10.8 kg 
vs 4.7 kg) and fat loss (7.8 kg vs 3.0 kg) at week 24 at 
affordable additional total direct cost (US$ 442.46 vs 
US$ 270.75) [6]. Large proportion of additional costs 
incurred from the evaluation of patients’ dietary rec-
ords.  
In a larger 12-month study conducted in the United 
Kingdom, Little at al. found that a web intervention 
with remote support resulted in similar weight loss 
outcomes as a web-intervention with the face-to-face 
nurse support [7]. Compared to common control group 
with evidence-based advice and simple materials only, 
web interventions with remote and face-to-face 
achieved additional 1.30 kg and 1.56 kg average weight 
loss with the estimated average incremental costs of 
£23 and -£36 over the 12-month study, respectively. 
Slightly higher proportion of remote support group 
maintained at least 5 % weight loss from baseline (32.4 
%) than in the face-to-face support group (29.2 %).  
A recent Finnish studies revealed that travel costs relat-
ed to screening of type 2 diabetes patients constitute a 
substantial cost item, the consideration of which in 
healthcare planning would enable the societal cost-
efficiency of care to be improved [31] and travelling 
costs including also productivity-related costs can im-
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pact the outcomes of cost-effectiveness analysis in 
multiple myeloma treatments [32]. These findings sup-
port, and are supported by, our finding that 12% to 16 
% of HWH’s PCF comes from travelling costs.  
A key strength of present study was the Finnish RWD 
utilized. Finnish register data and electronic health 
records are of high quality and cover practically all indi-
viduals with unique social insurance code. Unfortunate-
ly, the characteristics and the affordability of Finnish 
health care complicates generalization of the previous 
findings from other countries to the Finnish setting. A 
number of guidelines, recommendations and reporting 
rationale are available for carrying out health economic 
evaluations and register studies in the efficient Finnish 
system (e.g. [13,17-19]). In addition, in the present 
cost-benefit evaluation we applied the PICOSTEPS prin-
ciple [4,13,15], which has been previously successfully 
applied also in multiple other health economic evalua-
tion tasks (e.g. [12,13,15,16,32]).  
On the other hand, the key limitations of present analy-
sis are mainly related to perspective and time. As men-
tioned above, the analytical perspective was limited to 
payer perspective and direct costs, in line with the Finn-
ish recommendations [17,18]. Producer costs, such as 
development, staff training, production or maintenance 
costs related to CGC or HWH were not included, as 
these are assumed all to be covered by the price to 
payer.  
In line with the payer perspective, indirect costs were 
not considered, although they can be a significant or 
even the most significant cost driver in analyses with 
wider perspectives [32,34]. Costs, such as time costs, 
sickness allowances, early retirement, absenteeism, re-
education and unemployment due to obesity or associ-
ated comorbidities, would affect an analysis with wider 
societal perspective, and should be included in when 
evaluating the full societal effects of an intervention or 
disease. The direct cost perspective is likely to be con-
servative for HWH, as HWH resulted to less use of re-
sources and would likely also result to lower indirect 
costs than CGC. For instance, time costs or costs of 
work absenteeism related to physical health care visits 
or travelling were not considered in the analyses, thus 
at least partially underestimating the full benefit of 
web-based intervention.  
In addition to indirect costs, analysis also excluded 
direct costs related to primary and social care, as well 
as secondary care beyond the 5-year time horizon. 
Although, among unselected Finnish primary care pa-
tients, primary care costs constitute a significant pro-
portion of total health care costs [33], we did not have 
data regarding the primary or social care resource use 
or costs among patients treated for obesity in second-
ary care with CGC or HWH to support any assumption 
on how HWH would impact direct primary or social care 
costs. While that could be the case if, for instance, HWH 
is more effective than CGC, we conservatively assumed 
that HWH has no impact on primary care or social care 
costs. Less effective intervention would likely to be 
associated with higher direct long-term secondary care, 
primary care and social care costs, due to comorbidities 
associated with untreated obesity.  
Although effectiveness, cost-effectiveness or cost-utility 
were not in the focus and could not be assessed in the 
present study based on the data available, the analyses 
still are conservative for HWH. Namely, the HWH is not 
expected to be less effective than the CGC at popula-
tion level, nor are the results likely to get worse for 
HWH in a longer-term analysis covering also obesity-
associated conditions and mortality. This assumption 
seems credible, given that in a recent Finnish random-
ized trial the examined web-based health behavior 
support produced larger average weight loss main-
tained up to 24 months than the examined face-to-face 
cognitive behavioral therapy alone in the Finnish setting 
[18]. The study also demonstrated that the greatest 
weight loss was achieved, when web-based support 
was given in addition to cognitive behavioral therapy. 
Thus, HWH may produce better results than achievable 
by simpler web-based interventions without interactive 
coaching, because virtual coaching is an integral part of 
HWH. Unfortunately, large body of previous studies 
examining the effectiveness of various different web-
based interventions in different settings [5-11] are not 
comparable to HWH, nor transferable to the Finnish 
setting, and thus cannot be used to draw conclusions 
on the effectiveness of HWH.  
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However, HWH has a great potential for future studies 
and assessments, as participant data is collected up to 5 
years on weight, service use and other important indi-
cators such as lifestyle, motivations, body image, physi-
cal exercise, nutrition, medication, morbidity, perceived 
health, self-perceptions, psychological factors and 
sleep. Effects of HWH on weight management, health 
and quality of life of patients with obesity will be stud-
ied and reported in the future. Moreover, the future 
research aims also include assessing the factors predict-
ing long-term success in the weight management, pre-
dicting the long-term health outcomes achievable with 
HWH and estimating how cost-effective HWH could be 
when considering also the long-term outcomes, such as 
prevention of diabetes and cardiovascular diseases. An 
analysis using wider societal perspective and life-time 
horizon covering costs related to long-term effective-
ness would provide more comprehensive view on the 
full potential impacts of HWH in treatment of obesity.  
 
Conclusion 
HWH is a more affordable alternative to CGC, can po-
tentially be cost-saving, free capacity and allow more 
efficient use of resources targeted at combating the 
increasing obesity epidemic. HWH could enable weight 
management for larger populations than previously 
possible from both technical and budgetary perspec-
tives. 
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